P

Insulet Corp

D
PODD
USD
6.01
(2.5146%)
Market Closed
26,747.00
Volume
2.81
EPS
-
Div Yield
44.515
P/E
17,178,994,244.82
Market Cap
Today
2.5146%
1 Week
5.790%
1 Month
7.564%
6 Months
32.898%
12 Months
51.325%
Year To Date
12.908%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TNDM
-0.895
(-2.6177%)
USD
ISRG
ISRG
9.03
(1.752%)
USD
MDT
MDT
-1.99
(-2.2084%)
USD
ABT
ABT
-1.475
(-1.263%)
USD
DXCM
DXCM
0.21
(0.3056%)
USD
EW
EW
0.09
(0.1369%)
USD
PFE
PFE
0.135
(0.4941%)
USD
BSX
BSX
0.45
(0.5205%)
USD
T
TFX
-3.72
(-1.844%)
USD
Z
ZBH
-1.51
(-1.3702%)
USD

Title:
Insulet Corp

Sector:
Healthcare
Industry:
Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
Do you need help or have a question?
Contact Us